Cannabis Extract in Fibromyalgia Syndrome - the SUNRISE Study

Recruiting now

Conditions studied: Fibromyalgia (FM)

In brief

The aim of this observational study is to evaluate the effects of cannabis extract Avextra 10/10 solution on pain, fatigue, sleep, and quality of life among patients affected by fibromyalgia (FM) syndrome. The main question it aims to answer is: Does cannabis extract have a positive effect on pain after 12 weeks in these patients? Participants diagnosed from FM will be evaluated and will fill survey about their pain, fatigue, sleep, anxiety, depression and quality of life at baseline, 4 weeks, 8 weeks and 12 weeks after the initiation of cannabis extract Avextra 10/10 solution.

Key facts

Study ID
NCT06747039
Run by
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
People needed
38
Starts
2024-12-05
Expected to finish
2025-12-01
Last updated by the study team
2024-12-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.